Back to Search
ANTHONY HOWES, M.D.
M.D.
Radiation Oncology Physician
NPI: 1184711897Individual
Specialties, Licenses & Credentials
Research & Publications (20)
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures.
PMID 17766839·Mol Cancer Ther·2007
8-other
Separation of isotropic chemical and second-order quadrupolar shifts by multiple-quantum double rotation NMR.
PMID 19201231·J Magn Reson·2009
8-other
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
PMID 19470696·Blood·2009
3-trial
High-resolution 17O double-rotation NMR characterization of ring and non-ring oxygen in vitreous B2O3.
PMID 19652841·Phys Chem Chem Phys·2009
8-other
Critical role for caspase-8 in epidermal growth factor signaling.
PMID 19470771·Cancer Res·2009
7-preclinical
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.
PMID 17722061·J Neurosci Res·2008
7-preclinical
Designing information fusion for the encoding of visual-spatial information.
PMID 18484395·Ergonomics·2008
8-other
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.
PMID 17851757·Breast Cancer Res Treat·2008
3-trial
The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo.
PMID 17876043·Mol Cancer Ther·2007
7-preclinical
The determination of 17O NMR parameters of hydroxyl oxygen: a combined deuteration and DOR approach.
PMID 18157798·Magn Reson Chem·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4021 S 700 E, 300
SALT LAKE CITY, UT 84107 - Phone
- (800) 732-7176
Quick Facts
- NPI
- 1184711897
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile